More recently the same group showed that immunization of multiple doses of their IrPfSPZ vaccine by IV induced a high level of PfSPZ-specific T-cell responses, including that of CD8+ T cells, and conferred protection in six out of six (100%) human vaccinees against malaria challenge [16]. Here, CD8A is linked to malaria.